The share price is holding up well considering the overall market. This could be closer to 3.40ish leading up to end June (in anticipation of approval). Once approved this will fly IMHO. There are many large pharma that will be running the ruler over junior companies.
Ann: Bronchitol Deferred by Australian PBAC , page-18
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
0.002(5.00%) |
Mkt cap ! $57.67M | |||
| Open | High | Low | Value | Volume |
| 4.0¢ | 4.3¢ | 4.0¢ | $48.01K | 1.160M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1025000 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 461843 | 2 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SNT (ASX) Chart |